Single-dose psilocybin for a treatment-resistant episode of major depression.

“In this phase 2 trial involving participants with treatment-resistant depression, psilocybin at a single dose of 25 mg, but not 10 mg, reduced depression scores significantly more than a 1-mg dose over a period of 3 weeks but was associated with adverse effects.” learn more

Leave a Reply

Your email address will not be published. Required fields are marked *